Gemina Laboratories Ltd.
GLAB
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.90% | 47.25% | 43.35% | 38.16% | 15.06% |
| Total Depreciation and Amortization | 18.79% | 34.28% | 67.65% | 79.05% | 79.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.83% | -78.07% | -28.76% | -12.42% | 50.26% |
| Change in Net Operating Assets | 52.18% | 0.93% | 1,882.18% | 224.27% | 22.03% |
| Cash from Operations | 60.29% | 65.22% | 76.28% | 65.82% | 30.17% |
| Capital Expenditure | -- | 119.54% | 103.32% | 93.51% | 48.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 142.35% | 103.16% | 100.75% | 98.64% | 91.81% |
| Total Debt Issued | 355.00% | 355.00% | -- | -- | -- |
| Total Debt Repaid | -29.87% | -39.36% | -65.04% | -61.31% | -42.36% |
| Issuance of Common Stock | -83.82% | -85.25% | -85.25% | -100.00% | -30.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.58% | 70.35% | 69.09% | 96.07% | 81.21% |
| Cash from Financing | -60.13% | -63.78% | -57.22% | -87.17% | -22.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.70% | 106.31% | 103.10% | -225.63% | 90.71% |